FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to experimental medicine and oncogynaecology, and can be used for modelling uterine sarcoma. Female white outbred rats into the lumen of the right uterine horn using an intravenous catheter with an injection port of 22G, 0.9×25 mm, 0.5 ml of a tumour suspension of sarcoma M1 is injected in amount of 2.5–3.5×106 cells.
EFFECT: invention provides fast malignant growth of sarcoma in uterine body.
1 cl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CREATING ORTHOTOPIC ENDOMETRIAL CANCER MODEL | 2024 |
|
RU2818464C1 |
| METHOD FOR PREDICTION OF HIGH RISK OF RECURRENCE IN PATIENTS WITH IB STAGE OF CERVICAL CANCER WHO RECEIVED COMBINED TREATMENT | 2020 |
|
RU2732769C1 |
| METHOD FOR PREDICTING THE DURATION OF THE RELAPSE-FREE PERIOD OF SOFT TISSUE SARCOMAS OF THE EXTREMITIES IN MIDDLE-AGED AND ELDERLY WOMEN | 2022 |
|
RU2778616C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT NEOPLASMS OF OVARIES | 2018 |
|
RU2686180C1 |
| METHOD OF STIMULATING CHRONIC PAIN OF MALIGNANT GROWTH IN LUNG RATS | 2018 |
|
RU2676641C1 |
| METHOD FOR CREATING POLYNEOPLASIA WITH STIMULATION OF TUMOR GROWTH IN CONDITIONS OF PRIMARY IMMUNODEFICIENCY IN EXPERIMENT | 2021 |
|
RU2751930C1 |
| METHOD FOR PREDICTING THE PRESENCE OF SARCOMA IN WOMEN WITH PROLIFERATING UTERINE MYOMA | 2018 |
|
RU2682801C1 |
| METHOD OF PREDICTING RISK OF EARLY RECURRENCE OF ENDOMETRIAL SQUAMOUS CELL CARCINOMA IN PATIENTS WITH STAGE I OF DISEASE | 2023 |
|
RU2812609C1 |
| METHOD FOR CREATING AN EXPERIMENTAL MODEL OF TUMOR GROWTH IN CONDITIONS OF HYPOTHYROIDISM | 2021 |
|
RU2779358C1 |
| METHOD FOR SURGICAL TREATMENT OF METRA FIBROIDS IN WOMEN OF REPRODUCTIVE AGE | 2020 |
|
RU2750911C1 |
